Drug Shortage Report for TEVA-LENOLTEC NO. 2

Last updated on 2021-06-10 History
Report ID 138285
Drug Identification Number 00653241
Brand name TEVA-LENOLTEC NO. 2
Common or Proper name LENOLTEC NO.2 TAB
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) CODEINE PHOSPHATE CAFFEINE ACETAMINOPHEN
Strength(s) 15MG 15MG 300MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 500
ATC code N02AJ
ATC description OPIOIDS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2021-04-28
Estimated end date 2021-06-30
Actual end date 2021-06-09
Shortage status Resolved
Updated date 2021-06-10
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2021-06-10 French Compare
v7 2021-06-10 English Compare
v6 2021-06-03 French Compare
v5 2021-06-03 English Compare
v4 2021-05-10 French Compare
v3 2021-05-10 English Compare
v2 2021-04-29 French Compare
v1 2021-04-29 English Compare

Showing 1 to 8 of 8